Immunohistochemical Markers of Tumor Microenvironment as Prognostic Predictors in Diffuse Large B-Cell Lymphoma: Study from an Oncology Centre in South India

Introduction Diffuse large B-cell lymphoma (DLBCL) accounts for 60% of lymphomas in India. Although the survival of DLBCL patients has improved following the addition of rituximab, a subset of patients do not respond well to therapy. Among the several factors responsible for this varied response, tu...

Full description

Bibliographic Details
Main Authors: Indu R. Nair, Athulya Sadeesh, Pooja Phalak, Pavithran Keechilat
Format: Article
Language:English
Published: Thieme Medical Publishers, Inc. 2021-01-01
Series:Asian Journal of Oncology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1714305